TrialCardiovascular drugs and therapy2023

C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.

Sunao Kojima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.